Global Health Alert: WHO Raises Alarm Over Ebola Surge in DR Congo and Uganda

Date:

Share post:

The World Health Organization (WHO) has declared the ongoing Ebola outbreak in the Democratic Republic of Congo (DRC) and neighboring Uganda a Public Health Emergency of International Concern (PHEIC), following a sharp increase in infections and fatalities linked to the rare Bundibugyo strain of the virus.

Health officials report that the outbreak has already claimed dozens of lives, raising concerns over cross-border transmission and pressure on regional healthcare systems. WHO stated that the emergency declaration is intended to accelerate international support, improve surveillance, strengthen treatment facilities, and enhance coordination among affected nations.

Medical response teams are being deployed across high-risk areas while authorities intensify contact tracing, community awareness campaigns, and infection-control measures. WHO has also urged neighboring countries to remain vigilant and strengthen preparedness systems at borders and healthcare centers.

The development serves as a reminder of the continuing global threat posed by emerging infectious diseases and the importance of rapid public health response and international cooperation.

By Sharon Bose & Arundhuti Chatterjee

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Dabur India Plant Under US FDA Scanner Over Contamination Concerns

The United States Food and Drug Administration (US FDA) has flagged serious concerns at Dabur India's manufacturing facility...

FDA Approves Wockhardt’s Novel Antibiotic ZAYNICH™️ for cUTI

Wockhardt Limited  announced that the U.S. Food and Drug Administration (FDA) has approved ZAYNICH™ (cefepimeand zidebactam), a novel intravenous antibiotic...

Relief for Patients: NPPA Fixes Ceiling Prices for 30 Essential Medicines

The National Pharmaceutical Pricing Authority (NPPA) has notified ceiling prices for 30 essential fixed-dose combination medicines under the...

FDA Draft Guidance Aims to Reduce Animal Testing for Cancer Drugs

The U.S. Food and Drug Administration (FDA) issued a new draft guidance aimed at reducing unnecessary animal testing...